Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Cyclooxygenase regulates angiogenesis induced by colon cancer cells.

Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN.

Cell. 1998 May 29;93(5):705-16. Erratum in: Cell 1998 Jul 24;94(2):273.

2.

Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.

Sawaoka H, Tsuji S, Tsujii M, Gunawan ES, Sasaki Y, Kawano S, Hori M.

Lab Invest. 1999 Dec;79(12):1469-77.

PMID:
10616198
3.

Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.

Sengupta S, Sellers LA, Cindrova T, Skepper J, Gherardi E, Sasisekharan R, Fan TP.

Cancer Res. 2003 Dec 1;63(23):8351-9.

5.
7.

Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2.

Hernández GL, Volpert OV, Iñiguez MA, Lorenzo E, Martínez-Martínez S, Grau R, Fresno M, Redondo JM.

J Exp Med. 2001 Mar 5;193(5):607-20.

8.
9.

15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.

Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM, Lippman SM.

Cancer Res. 2000 Dec 15;60(24):6846-50.

10.

Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.

Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL.

Cancer Res. 2002 Feb 1;62(3):625-31.

11.

Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.

Yasumaru M, Tsuji S, Tsujii M, Irie T, Komori M, Kimura A, Nishida T, Kakiuchi Y, Kawai N, Murata H, Horimoto M, Sasaki Y, Hayashi N, Kawano S, Hori M.

Cancer Res. 2003 Oct 15;63(20):6726-34.

12.

Cyclooxygenase-2 in cancer cells and macrophages induces colon cancer cell growth by cigarette smoke extract.

Liu ES, Shin VY, Ye YN, Luo JC, Wu WK, Cho CH.

Eur J Pharmacol. 2005 Jul 25;518(1):47-55.

PMID:
15993407
13.
14.

Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis.

Daniel TO, Liu H, Morrow JD, Crews BC, Marnett LJ.

Cancer Res. 1999 Sep 15;59(18):4574-7.

15.

IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells.

Di Popolo A, Memoli A, Apicella A, Tuccillo C, di Palma A, Ricchi P, Acquaviva AM, Zarrilli R.

Oncogene. 2000 Nov 16;19(48):5517-24.

16.

COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.

Grösch S, Tegeder I, Niederberger E, Bräutigam L, Geisslinger G.

FASEB J. 2001 Dec;15(14):2742-4. Epub 2001 Oct 15.

PMID:
11606477
17.

Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor.

Eibl G, Takata Y, Boros LG, Liu J, Okada Y, Reber HA, Hines OJ.

Cancer Res. 2005 Feb 1;65(3):982-90.

18.

Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells.

Li G, Yang T, Yan J.

Biochem Biophys Res Commun. 2002 Dec 20;299(5):886-90.

PMID:
12470662
19.

Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis.

Fosslien E.

Ann Clin Lab Sci. 2001 Oct;31(4):325-48. Review.

PMID:
11688844
20.

Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.

Spinella F, Rosanò L, Di Castro V, Nicotra MR, Natali PG, Bagnato A.

Clin Cancer Res. 2004 Jul 15;10(14):4670-9.

Supplemental Content

Support Center